At 12.30 next Thursday, creditors of Pharmapod will log on to a Zoom conference call to liquidate the business formally. The liquidation is not a surprise, and it is unlikely to be controversial. After all, the company’s assets and intellectual property have already been commandeered, and quickly sold, by its largest creditor. But it will also mark the formal end of a business that raised millions of euro in funding and generated a string of high-profile international deals. Founded by pharmacist-cum-entrepreneur Leonora O’Brien in 2012, Pharmapod developed a cloud-based platform to reduce medication errors for patients. The company was attempting…

Want to read the full story?

Unlock this article – and everything else on The Currency – with an annual membership and receive a free Samsonite Upscape suitcase, retailing at €235, delivered to your door.

Subscribe

Cancel at any time.

Are you already a member? .